These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 29046446)

  • 1. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulated Foamy Viral Vectors.
    Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
    Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
    Suerth JD; Maetzig T; Brugman MH; Heinz N; Appelt JU; Kaufmann KB; Schmidt M; Grez M; Modlich U; Baum C; Schambach A
    Mol Ther; 2012 May; 20(5):1022-32. PubMed ID: 22334016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.
    Zhou S; Fatima S; Ma Z; Wang YD; Lu T; Janke LJ; Du Y; Sorrentino BP
    Mol Ther; 2016 Jun; 24(6):1090-1099. PubMed ID: 26957223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Vectors: The Road to Reducing Genotoxicity.
    David RM; Doherty AT
    Toxicol Sci; 2017 Feb; 155(2):315-325. PubMed ID: 27803388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
    Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
    Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.
    Ikawa Y; Uchiyama T; Jagadeesh GJ; Candotti F
    Gene Ther; 2016 Nov; 23(11):815-818. PubMed ID: 27487944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region.
    Arumugam PI; Higashimoto T; Urbinati F; Modlich U; Nestheide S; Xia P; Fox C; Corsinotti A; Baum C; Malik P
    Mol Ther; 2009 Nov; 17(11):1929-37. PubMed ID: 19707188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the in vivo safety of insulated foamy viral vectors.
    Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
    Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
    Rethwilm A
    Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors.
    Manic G; Maurin-Marlin A; Galluzzi L; Subra F; Mouscadet JF; Bury-Moné S
    Hum Gene Ther Methods; 2012 Apr; 23(2):84-97. PubMed ID: 22456436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
    Everson EM; Hocum JD; Trobridge GD
    J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element.
    Hanawa H; Yamamoto M; Zhao H; Shimada T; Persons DA
    Mol Ther; 2009 Apr; 17(4):667-74. PubMed ID: 19223867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
    Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
    Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.
    Scholz SJ; Fronza R; Bartholomä CC; Cesana D; Montini E; von Kalle C; Gil-Farina I; Schmidt M
    Hum Gene Ther; 2017 Oct; 28(10):875-885. PubMed ID: 28825370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.
    Montini E; Cesana D; Schmidt M; Sanvito F; Bartholomae CC; Ranzani M; Benedicenti F; Sergi LS; Ambrosi A; Ponzoni M; Doglioni C; Di Serio C; von Kalle C; Naldini L
    J Clin Invest; 2009 Apr; 119(4):964-75. PubMed ID: 19307726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector.
    Evans-Galea MV; Wielgosz MM; Hanawa H; Srivastava DK; Nienhuis AW
    Mol Ther; 2007 Apr; 15(4):801-9. PubMed ID: 17299406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator.
    Ramezani A; Hawley TS; Hawley RG
    Blood; 2003 Jun; 101(12):4717-24. PubMed ID: 12586614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
    Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
    Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.
    Ryu BY; Evans-Galea MV; Gray JT; Bodine DM; Persons DA; Nienhuis AW
    Blood; 2008 Feb; 111(4):1866-75. PubMed ID: 17991809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.